Answers are grounded in this paper and cite their sources.
The lack of innovative standards for biosafety in synthetic biology is an unresolved policy gap that limits many potential applications in synthetic biology. We argue that a massive support for standardization in biosafety is required for synthetic biology to flourish.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: